ATE92960T1 - Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren. - Google Patents

Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.

Info

Publication number
ATE92960T1
ATE92960T1 AT87401301T AT87401301T ATE92960T1 AT E92960 T1 ATE92960 T1 AT E92960T1 AT 87401301 T AT87401301 T AT 87401301T AT 87401301 T AT87401301 T AT 87401301T AT E92960 T1 ATE92960 T1 AT E92960T1
Authority
AT
Austria
Prior art keywords
alpha
particularly use
kallikrein inhibitors
antitrypsin variants
antitrypsin
Prior art date
Application number
AT87401301T
Other languages
English (en)
Inventor
Sophie Jallat
Michael Courtney
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE92960T1 publication Critical patent/ATE92960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87401301T 1986-06-10 1987-06-10 Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren. ATE92960T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608386A FR2599752B1 (fr) 1986-06-10 1986-06-10 Variants de l'alpha1- antitrypsine utiles notamment comme inhibiteurs de la kallikreine
EP87401301A EP0253690B1 (de) 1986-06-10 1987-06-10 Alpha-1-antitrypsin-Varianten, besonders verwendbar als Kallikrein-Inhibitoren

Publications (1)

Publication Number Publication Date
ATE92960T1 true ATE92960T1 (de) 1993-08-15

Family

ID=9336200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401301T ATE92960T1 (de) 1986-06-10 1987-06-10 Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.

Country Status (13)

Country Link
US (1) US4973668A (de)
EP (1) EP0253690B1 (de)
JP (1) JP2649804B2 (de)
KR (1) KR880000575A (de)
AT (1) ATE92960T1 (de)
AU (1) AU610500B2 (de)
CA (1) CA1328706C (de)
DE (1) DE3786961T2 (de)
DK (1) DK173131B1 (de)
FR (1) FR2599752B1 (de)
IE (1) IE61060B1 (de)
PT (1) PT85047B (de)
ZA (1) ZA874123B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0401508T3 (da) * 1989-05-13 1995-05-15 Bayer Ag Proteaseinhibitorer, fremgangsmåde til deres fremstilling samt lægemidler med indhold deraf
WO1993018159A2 (en) 1992-03-09 1993-09-16 Chiron Corporation Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells
AU7257994A (en) * 1993-07-09 1995-02-06 Michael Laskowski Novel protein inhibitors of serine proteinases (e.g. furin) derived from turkey ovomucoid third domain
AU3479495A (en) * 1994-09-30 1996-04-26 Ppl Therapeutics (Scotland) Ltd Alpha-1-antitrypsin and antithrombine-iii variants
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
EP2369930A4 (de) * 2008-12-02 2012-10-03 Joslin Diabetes Ct Verfahren zur senkung des blutdrucks anhand von plasma-kallikrein-hemmern
EP3320922A1 (de) 2011-06-10 2018-05-16 Ionis Pharmaceuticals, Inc. Verfahren zur modulierung der kallikrein (klkb1)-expression
US9322021B2 (en) 2011-06-29 2016-04-26 Ionis Pharmaceuticals, Inc. Methods for modulating kallikrein (KLKB1) expression
KR102365486B1 (ko) 2013-08-28 2022-02-18 아이오니스 파마수티컬즈, 인코포레이티드 프리칼리크레인 (pkk) 발현의 조절
GB201322091D0 (en) 2013-12-13 2014-01-29 Cambridge Entpr Ltd Modified serpins for the treatment of bleeding disorders
HUE052709T2 (hu) 2014-05-01 2021-05-28 Ionis Pharmaceuticals Inc Módosított antiszensz oligonukleotidok konjugátumai és azok alkalmazása PKK expressziójának módosítására
WO2018154044A1 (en) 2017-02-23 2018-08-30 Umc Utrecht Holding B.V. Modified serpins for the treatment of bradykinin-mediated disease
EP3600345A4 (de) * 2017-03-29 2021-01-06 Cornell University Oxidationsresistente aat-gentherapie

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107278B1 (de) * 1982-08-04 1989-11-15 National Research Development Corporation Molekulare Klonierung des Gens für menschlichen antihaemophilischen Faktor IX
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
EP0164719B1 (de) * 1984-06-14 1992-05-06 Chiron Corporation Protease-Inhibitoren des Alpha-1-Antitrypsin Typs mit modifizierter aktiever Stelle und deren Herstellung
EP0169114B1 (de) * 1984-06-19 1991-01-16 Transgene S.A. Derivate des menschlichen alpha-1-Antitrypins und Verfahren zu deren Herstellung
CA1299120C (en) * 1984-10-22 1992-04-21 Glenn Kawasaki Stable dna constructs for expression of alpha-1-antitrypsin
DE3684947D1 (de) * 1985-03-15 1992-05-27 Nat Res Dev Faktor-ix-protein.
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4770999A (en) * 1985-04-22 1988-09-13 Genetics Institute, Inc. High yield production of active Factor IX
FR2601033B1 (fr) * 1986-07-02 1990-01-19 Transgene Sa Variants de l'alpha-antitryspine humaine glycosylee et procede pour la preparation

Also Published As

Publication number Publication date
CA1328706C (fr) 1994-04-19
PT85047B (pt) 1990-03-08
EP0253690B1 (de) 1993-08-11
JP2649804B2 (ja) 1997-09-03
PT85047A (fr) 1987-07-01
DE3786961T2 (de) 1994-01-20
KR880000575A (ko) 1988-03-26
EP0253690A1 (de) 1988-01-20
DK173131B1 (da) 2000-01-31
ZA874123B (en) 1987-12-09
FR2599752A1 (fr) 1987-12-11
FR2599752B1 (fr) 1989-11-03
DE3786961D1 (de) 1993-09-16
JPS6379899A (ja) 1988-04-09
US4973668A (en) 1990-11-27
IE61060B1 (en) 1994-09-21
DK285087A (da) 1987-12-11
DK285087D0 (da) 1987-06-03
IE871374L (en) 1987-12-10
AU7362587A (en) 1987-12-17
AU610500B2 (en) 1991-05-23

Similar Documents

Publication Publication Date Title
ES2148140T3 (es) Inhibidores de la biosintesis del oxido nitrico.
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
ES2173341T3 (es) Compuestos inhibidores de proteasa retroviral.
ATE92960T1 (de) Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.
AP9200410A0 (en) Retroviral protease inhibitors.
DK0607334T3 (da) Cycliske urinstoffer og analoger anvendelige som retrovirale proteasehæmmere
YU20199A (sh) Heterociklični sukcinimidi i njihova primena kao metaloproteinaznih inhibitora
ES2088839T3 (es) Compuestos que inhiben las proteasas retrovirales.
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
ATE225771T1 (de) Prostaglandin-pharmazeutische-zusammensetzungen
ES2184097T3 (es) Nuevos compuestos.
FI935777A0 (fi) Inhibitorer foer HIV-proteas anvaendbara vid behandling av AIDS
NO951593D0 (no) Nye substituerte azetidinoner som antiinflammatoriske og antidegenerative midler
ES2052560T3 (es) Compuestos difluorcetonicos.
DE69728164D1 (de) Peptidomimetische inhibitoren von der protease des menschlichen cytomegalovirus
ES2051954T3 (es) 2-aminotiazoles substituidos.
FI951078A0 (fi) Retrovirusinfektion inhibitio
DE50104100D1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c
ES2060711T3 (es) 2-aminotiazoles substituidos.
ECSP993018A (es) Nuevos inhibidores de proteasas, particularmente inhibidores de cisteina y serina proteasas
FI935707L (fi) Anvaendning av hirudinderivat som trombininhibitorer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee